Telix Acquires Advanced Nuclear Medicine Ingredients SA
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Appendix 4C - September Quarter
- Telix Commences ZIRCON Phase III Renal Cancer Imaging Trial
- Interim Analysis of ZIR-DOSE Study Shows Improved Dosimetry
- Telix and ANMI Expand PSMA Imaging Partnership
- Cyclotek Manufacturing Partnership for Kidney Cancer Imaging
Later from Telix Pharmaceuticals
- ANMI Transaction - Market Briefing
- Nihon Medi-Physics Collaboration on Actinium Renal Cancer
- Telix Pharmaceuticals Completes Acquisition of ANMI SA
- Update - Acceleration of Prostate Cancer Therapy Program
- Detailed Program Update - January 2019
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals